The federal 340B Drug Pricing Program was created with a straightforward goal: help low-income and uninsured patients gain access to affordable medicines. But according to Public Policy Solutions co-founder Joe Grogan, the program has drifted far from its original mission.
In a new op-ed for the Daily Caller News Foundation, Public Policy Solutions co-founder Joe Grogan examines the fierce backlash against proposals requiring nonprofit hospitals to demonstrate how they use their tax-exempt status to benefit patients and communities.
In his recent op-ed, “Don’t Silence Patients: Protect Transparency, Free Speech and Patient Outcomes,” for the Washington Legal Foundation, John “CZ” Czwartacki, Co-Founder and Principal of Public Policy Solutions, argues that stricter regulations on direct-to-consumer pharmaceutical advertising could ultimately harm patients by limiting access to important medical information.
In a recent op-ed, Public Policy Solutions co-founder Joe Grogan argues that Sen. Bernie Sanders is undermining America’s artificial intelligence leadership by hosting Chinese AI officials linked to Beijing while pushing policies that would slow U.S. data center expansion.
Joe Grogan, co-founder and president of Public Policy Solution, argues in his recently published op-ed “Americans deserve more than an ‘incomplete’ filing in Union Pacific and Norfolk Southern rail merger,” that the merger between Union Pacific and Norfolk Southern raises serious concerns about competition, safety, and rising costs across the U.S. freight rail system.
In their recent op-ed, “How Congress can deliver healthcare affordability and mitigate Inflation Reduction Act disaster,” Public Policy Solutions’ President Joe Grogan and Co-Founder John Czwartacki argue that despite broader economic improvements, healthcare costs remain high, largely due to provisions in the Inflation Reduction Act (IRA) that they say have increased premiums, reduced plan options, and disrupted Medicare drug programs.
In his latest op-ed, “Is cheaper better if it kills cancer cures?” Public Policy Solutions President Joe Grogan argues that while lowering drug prices is an important goal, focusing solely on cheaper medications can come at the cost of innovation and access to newer, more effective treatments.
In his recent op-ed, “Trump’s energy policies are paying off,” Joe Grogan, President of Public Policy Solutions, argues that President Donald Trump’s energy policies are strengthening American energy production and helping restore U.S. energy dominance.
In his op-ed, “Trump Admin Takes Pro-Patient Approach to Drug Prices,” Public Policy Solution’s President Joe Grogan argues that initiatives like the TrumpRx platform, which offers discounted cash prices on dozens of high-demand medications, are designed to foster competition and allow consumers to bypass opaque middlemen such as pharmacy benefit managers (PBMs). The broader strategy […]
In a recent op-ed, “Trump Bets on Nuclear to Power AI Century,” Public Policy Solutions President Joe Grogan argues that nuclear energy is uniquely positioned to meet the massive, constant power needs of AI infrastructure and data centers. Expanding advanced nuclear technologies, such as small modular reactors, could help ensure that the U.S. maintains technological leadership while protecting consumers from rising electricity costs.